Predicting Relapse in Patients With Small Cell Neuroendocrine Carcinomas of the Urothelial Tract

Mohammad Jad Moussa, MD, MSc, of University of Texas MD Anderson Cancer Center, provides an overview of his research on prognostic factors of relapse in surgically resected small cell neuroendocrine carcinomas of the urothelial tract.

He shares how the persistence of the small cell component at resection may influence the current approach to adjuvant therapy for these patients.